Cleared Special

K102812 - GAMMA-BSM (FDA 510(k) Clearance)

Also includes:
BETA-BSM EQUIVABONE
Dec 2010
Decision
66d
Days
Class 2
Risk

K102812 is an FDA 510(k) clearance for the GAMMA-BSM. This device is classified as a Bone Grafting Material, Synthetic (Class II - Special Controls, product code LYC).

Submitted by Etex Corporation (Cambridge, US). The FDA issued a Cleared decision on December 3, 2010, 66 days after receiving the submission on September 28, 2010.

This device falls under the Dental FDA review panel. Regulated under 21 CFR 872.3930. A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw..

Submission Details

510(k) Number K102812 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 28, 2010
Decision Date December 03, 2010
Days to Decision 66 days
Submission Type Special
Review Panel Dental (DE)
Summary Summary PDF

Device Classification

Product Code LYC - Bone Grafting Material, Synthetic
Device Class Class II - Special Controls
CFR Regulation 21 CFR 872.3930
Definition A Synthetic Bone Grafting Material Is Synthetically-derived Device, Such As Hydroxylapatite, Intended To Fill, Augment, Or Reconstruct Periodontal And Or Bony Defects Of The Upper Or Lower Jaw.